Form 4 for VCYT VERACYTE, INC.
Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-05 · accession 0001384101-22-000113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-09 | 2022-08-05 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $7.85 | +5 | 71.1K | +0.0% | +$39.23 |
| D | 2022-08-09 | 2022-08-05 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | A - Grant | $0.00 | +10.7K | 71.1K | +18% | $0 |
| D | 2022-08-09 | 2022-08-05 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | S - Sale+OE | $26.54 | -1,028 | 70.0K | -1% | -$27.3K |
| DM | 2022-08-09 | 2022-08-05 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $0.00 | -5 | 0 | -100% | $0 |
| D | 2022-08-09 | 2022-08-05 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | A - Grant | $0.00 | +18.2K | 18.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | M | A | 1 | $5.43 | 71,060 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-05 | M | A | 2 | $6.45 | 71,059 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-05 | A | A | 10,702 | $0.00 | 71,055 | D | — | — | |
| 4 | Common | Common Stock | 2022-08-05 | S | D | 1,028 | $26.54 | 70,032 | D | — | — | |
| 5 | Common | Common Stock | 2022-08-05 | M | A | 2 | $10.45 | 71,057 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2022-08-05 | M | D | 1 | $0.00 | 0 | D | $5.43 · — to 2026-03-14 | 1 Common Stock | (F4) The option is fully vested. |
| 7 | Derivative | Stock Option (right to buy) | 2022-08-05 | M | D | 2 | $0.00 | 0 | D | $6.45 · — to 2026-02-28 | 2 Common Stock | (F4) The option is fully vested. |
| 8 | Derivative | Stock Option (right to buy) | 2022-08-05 | M | D | 2 | $0.00 | 0 | D | $10.45 · — to 2024-09-15 | 2 Common Stock | (F4) The option is fully vested. |
| 9 | Derivative | Stock Option (right to buy) | 2022-08-05 | A | A | 18,248 | $0.00 | 18,248 | D | $27.90 · — to 2032-08-05 | 18,248 Common Stock | (F3) The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter. |